Comment on "The risk assessment of uveitis after COVID-19 diagnosis"
J Med Virol
.
2024 Mar;96(3):e29494.
doi: 10.1002/jmv.29494.
Authors
Patrick Wu
1
,
Chin-Yuan Yii
2
,
Su-Boon Yong
3
4
5
Affiliations
1
College of Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.
2
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Landseed International Hospital, Taoyuan, Taiwan.
3
Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan.
4
Department of Medicine, China Medical University, Taichung, Taiwan.
5
Center for Allergy, Immunology, and Microbiome (A.I.M.), China Medical University Hospital, Taichung, Taiwan.
PMID:
38402601
DOI:
10.1002/jmv.29494
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Testing
COVID-19* / diagnosis
Humans
Risk Assessment
Uveitis* / diagnosis
Uveitis* / etiology